STACEY TATROE: Open Payments
NPI 1811357502 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,765 in 21 payments from 8 companies in 2025. Trend: 2023 $2,411 · 2024 $283 · 2025 $2,765
Food & beverage: $1,281Consulting: $1,260Travel & lodging: $224
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 3 | $1,512 |
| Amgen Inc. | 8 | $684 |
| Lundbeck LLC | 2 | $202 |
| TG Therapeutics, Inc. | 1 | $125 |
| Biogen, Inc. | 3 | $117 |
| Genentech, Inc. | 2 | $60 |
| Alexion Pharmaceuticals, Inc. | 1 | $41 |
| ABBVIE INC. | 1 | $23 |
Products named: Ocrevus, UPLIZNA, KRYSTEXXA, VYEPTI, BRIUMVI, TYSABRI, ULTOMIRIS, VYALEV.
Industry payments across GA — which companies pay providers there.
